期刊文献+

92例腮腺癌治疗分析

Analysis of the Treatment of 92 Cases of Parotid Carcinoma
暂未订购
导出
摘要 目的 分析手术、化疗联合治疗腮腺癌的效果。方法 术前或术中通过病理诊断将 92例腮腺癌分为低度恶性和高度恶性两种。低度恶性行腺叶及肿瘤切除术 ;高度恶性宜扩大切除。对淋巴结阳性者和Ⅲ~Ⅳ期高度恶性者应行腮颈联合根治术。术后在身体、血象允许情况下给予化疗 ,分局部化疗和全身化疗二种。结果  92例腮腺癌 5年、10年生存率分别为 72 8%、5 8 7% ,其中低度恶性者 5年、10年生存率分别为 95 1%、82 9% ;高度恶性者 5年、10年生存率分别为 5 8 3 %、43 1%。总淋巴结转移率为 2 5 0 %。结论 将腮腺癌治疗区分为低度恶性和高度恶性是可行的。合并化疗做为辅助性治疗是必要的 ,它可明显降低术后复发率 ,提高 5年、10年生存率。 Objective To evaluate the efficiency of operation combined with chemotherapy in the treatment of parotid carcinoma.Methods 92 cases of parotid carcinoma were divided into two grouaps,the lower malignancy and higher malignancy,by pathological examination.excision of tumor and parotid were performed on the lower;extended resection were performed on the higher.Then all the cases were treated with chemotherapy under the permission of the state of the health and blood cell.Chemotherapy was divided into local chemotherapy and general chemotherapy.Results The survival rate of 5 or 10 years for 92 cases of parotid carcinoma is 72.8% and 58.7% respectively.For the lower malignancy,the 5 or 10 years survival rate is 95.1% and 82.9%,For the higher malignancy,the survival rate of 5 or 10 years is 58.3% and 43.1%.The rate of LN metastases makes up 25.0% of the total.Conclusions The therapeatic method is feasible.The combined chemotherapy used as subsidiary therapay is necessary.It can reduce the recurrence rate and increase the survival rate.
出处 《河南肿瘤学杂志》 2000年第5期327-328,共2页 Henan Journal of Oncology
关键词 腮腺癌 化疗 颈淋巴清扫术 治疗 parotid carcionoma chemotherapy neck dissection
  • 相关文献

参考文献2

  • 1周正炎.涎腺癌[J].口腔颌面外科杂志,1995,5(1):41-43. 被引量:20
  • 2金友仁,沈言备,马光生,胡勤刚,陆东辉.腮腺癌的治疗──148例回顾性研究[J]口腔医学纵横,1995(01).

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部